Robert HOFMEISTER

Person

Scituate, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,965,012
- Issue date Apr 23, 2024
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,851,491
- Issue date Dec 26, 2023
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,377,638
- Issue date Jul 5, 2022
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,242,376
- Issue date Feb 8, 2022
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,085,021
- Issue date Aug 10, 2021
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,028,142
- Issue date Jun 8, 2021
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biological materials related to HER3
- Patent number 10,808,032
- Issue date Oct 20, 2020
- Ablynx N.V.
- Christine Knuehl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 10,442,849
- Issue date Oct 15, 2019
- TCR2 THERABEUTICS INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 10,358,474
- Issue date Jul 23, 2019
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 10,358,473
- Issue date Jul 23, 2019
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 10,208,285
- Issue date Feb 19, 2019
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biological materials related to HER3
- Patent number 9,932,403
- Issue date Apr 3, 2018
- Ablynx N.V.
- Christine Knuehl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific deimmunized CD3-binders
- Patent number 9,102,736
- Issue date Aug 11, 2015
- Amgen Research (Munich) GmbH
- Robert Hofmeister
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20240301026
- Publication date Sep 12, 2024
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING CD70 SPECIFIC...
- Publication number 20240252641
- Publication date Aug 1, 2024
- TCR2 Therapeutics Inc.
- Robert Hofmeister
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20240117002
- Publication date Apr 11, 2024
- Robert TIGHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR AUTOIMMUNITY REGULATION
- Publication number 20230338421
- Publication date Oct 26, 2023
- TCR2 Therapeutics Inc.
- Daniel GETTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20230235010
- Publication date Jul 27, 2023
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR GAMMA DELTA TCR REPROGRAMMING USING FU...
- Publication number 20230069322
- Publication date Mar 2, 2023
- TCR2 Therapeutics Inc.
- Jian DING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20230065936
- Publication date Mar 2, 2023
- TCR2 Therapeutics Inc.
- Alfonso QUINTÁS-CARDAMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20220362295
- Publication date Nov 17, 2022
- TCR2 Therapeutics Inc.
- Philippe KIEFFER-KWON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20220298478
- Publication date Sep 22, 2022
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210361704
- Publication date Nov 25, 2021
- TCR2 Therapeutics Inc.
- Patrick Alexander BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING TARGET SPECIFI...
- Publication number 20210315933
- Publication date Oct 14, 2021
- TCR2 Therapeutics Inc.
- Patrick Alexander Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210253666
- Publication date Aug 19, 2021
- TCR2 Therapeutics Inc.
- Patrick Alexander Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210206827
- Publication date Jul 8, 2021
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED T CELLS FOR THE TREATMENT OF CANCER
- Publication number 20210187022
- Publication date Jun 24, 2021
- TCR2 Therapeutics Inc.
- Daniel GETTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210079057
- Publication date Mar 18, 2021
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20200362011
- Publication date Nov 19, 2020
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20200362306
- Publication date Nov 19, 2020
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20200207828
- Publication date Jul 2, 2020
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20190276540
- Publication date Sep 12, 2019
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20190256571
- Publication date Aug 22, 2019
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20190177694
- Publication date Jun 13, 2019
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOLOGICAL MATERIALS RELATED TO HER3
- Publication number 20190023796
- Publication date Jan 24, 2019
- Ablynx N.V.
- Christine KNUEHL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20180251514
- Publication date Sep 6, 2018
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20180244747
- Publication date Aug 30, 2018
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20180230429
- Publication date Aug 16, 2018
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20170166622
- Publication date Jun 15, 2017
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC DEIMMUNIZED CD3-BINDERS
- Publication number 20130224205
- Publication date Aug 29, 2013
- Micromet AG
- Robert HOFMEISTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOLOGICAL MATERIALS RELATED TO HER3
- Publication number 20130136748
- Publication date May 30, 2013
- Merck Patent GmbH
- Christine Knuehl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOMAIN-GRAFTED ANTIBODIES
- Publication number 20090241202
- Publication date Sep 24, 2009
- MICROMET AG
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multispecific deimmunized CD3-binders
- Publication number 20090022738
- Publication date Jan 22, 2009
- Micromet AG
- Robert Hofmeister
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert HOFMEISTER

Person

Patents Grantslast 30 patents

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Biological materials related to HER3

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Biological materials related to HER3

Multispecific deimmunized CD3-binders

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING CD70 SPECIFIC...

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR AUTOIMMUNITY REGULATION

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR GAMMA DELTA TCR REPROGRAMMING USING FU...

COMPOSITIONS AND METHODS FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING TARGET SPECIFI...

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

BIOLOGICAL MATERIALS RELATED TO HER3

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

MULTISPECIFIC DEIMMUNIZED CD3-BINDERS

BIOLOGICAL MATERIALS RELATED TO HER3

DOMAIN-GRAFTED ANTIBODIES

Multispecific deimmunized CD3-binders